A competitor to Elon Musk’s Neuralink said it raised $20 million, enough to get it on track to introduce a new generation of powerful and tiny electrodes to the human brain.
Paradromics Inc., founded in 2015 about a year ahead of Neuralink, is building brain-computer interfaces that could help people with disorders ranging from paralysis to speech impediments. [Read more…] about Neurotech start-up Paradromics raises $20M to address brain-related disorders via next-gen brain-computer interfaces
“In 2003, neurologist Helen Mayberg of Emory University in Atlanta began to test a bold, experimental treatment for people with severe depression, which involved implanting metal electrodes deep in the brain in a region called area 25. The initial data were promising; eventually, they convinced a device company, St. Jude Medical in Saint Paul, to sponsor a 200-person clinical trial dubbed BROADEN.
This month, however, [Read more…] about Ethical issues raised around deep brain stimulation (DBS) research